Five‐year follow‐up study of hyperechogenicity of the substantia nigra in Parkinson's disease
Top Cited Papers
- 9 March 2005
- journal article
- research article
- Published by Wiley in Movement Disorders
- Vol. 20 (3) , 383-385
- https://doi.org/10.1002/mds.20311
Abstract
Using transcranial sonography, an area of hyperechogenicity at the substantia nigra (SN) may be detected as a typical marker in patients with Parkinson's disease (PD) as well as in approximately 9% of healthy subjects vulnerable to nigrostriatal impairment. In this longitudinal study, we provide evidence that the area of SN hyperechogenicity does not change in the course of PD. In conjunction with earlier findings in children and adolescents, this evidence indicates that, from late adolescence onward, this ultrasound finding is a trait marker for nigrostriatal vulnerability. © 2004 Movement Disorder SocietyKeywords
This publication has 8 references indexed in Scilit:
- Echogenicity of the substantia nigra in relatives of patients with sporadic Parkinson’s diseaseNeuroImage, 2003
- Echogenicity of the Substantia NigraArchives of Neurology, 2002
- Substantia nigra echogenicity is normal in non-extrapyramidal cerebral disorders but increased in Parkinson's disease.Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 2002
- Echogenicity of the substantia nigra in Parkinson's disease and its relation to clinical findingsZeitschrift für Neurologie, 2001
- Vulnerability of the nigrostriatal system as detected by transcranial ultrasoundNeurology, 1999
- Iron accumulation in the substantia nigra in rats visualized by ultrasoundUltrasound in Medicine & Biology, 1999
- Degeneration of substantia nigra in chronic Parkinson's disease visualized by transcranial color-coded real-time sonographyNeurology, 1995
- Altered Brain Metabolism of Iron as a Cause of Neurodegenerative Diseases?Journal of Neurochemistry, 1994